Letters

Spironolactone and risk of upper gastrointestinal events: Spironolactone may not be guilty

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7566.500-c (Published 31 August 2006) Cite this as: BMJ 2006;333:500
  1. Eugene Campbell, research fellow (eugene.campbell@nottingham.ac.uk),
  2. Anthony Shonde, research fellow,
  3. Stephen Foley, research fellow
  1. University of Nottingham, Nottingham NG7 2UH

    EDITOR—Verhamme et al present their data and case for warning patients on spironolactone about an increased risk of upper gastrointestinal bleeding.1 They use an electronic database and conditional logistic regression analysis with adjustments. We do …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe